Source link : https://www.newshealth.biz/health-news/novel-treatments-for-cutaneous-neurofibromas-show-promise/
In the opinion of R. Rox Anderson, MD, patients with neurofibromatosis type 1 (NF1) have long been underserved in the medical field. This tumor-predisposition syndrome affects an estimated 1 in 3500 people and is caused by heterozygous loss of NF1, a gene “that’s the size of a barn and is prone to getting loss of […]
Author : News Health
Publish date : 2025-01-23 21:52:54
Copyright for syndicated content belongs to the linked Source.
inHealth